Coldstream Capital Management Inc Sage Therapeutics, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAGE
# of Institutions
219Shares Held
51.2MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$34.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$33.6 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29.6 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$18.1 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.8 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $393M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...